Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rewinding RX vs T2D.com

Rewinding RX
Graded #340

Higher grade

vs+6.5
T2D.com
Graded #475

Lower grade

The verdict

Rewinding RX takes it — 59.5/100 to 53/100.

Rewinding RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rewinding RX is a longevity-focused telehealth platform that frames compounded GLP-1 therapy within a broader biological-age-reversal program alongside NAD+ and functional-medicine protocols.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRewinding RX +16
45
29
Dose & formulationT2D.com +24
40
64
Clinical oversightRewinding RX +16
85
69
Labs & monitoringRewinding RX +1
53
52
FulfillmentRewinding RX +29
87
58
Contract termsRewinding RX +6
61
55
Rewinding RX · left barT2D.com · right bar

The numbers

MetricRewinding RXT2D.com
WeighScore59.5/10053/100
GradeCC
Scorecard rank#340#475
SemaglutideNot disclosed$999/mo (starting dose, compounded)
TirzepatideNot disclosed$999/mo (starting dose, compounded)
CoverageAll 50 states1 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Rewinding RX

Graded #340 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer — uncommon transparency
  • MD-only physician network ('never a physician assistant or nurse')
  • All-50-state coverage with physician state-licensing matching
  • Corporate entity disclosed (Rewinding RX Ltd.)

Where it loses points

  • Pricing not shown — fully gated behind sign-up
  • Pharmacy partner not named (only generic 503A/503B references)
  • Medical director / clinical leadership not disclosed
  • Governing law, arbitration venue, and corporate address not disclosed
  • Tirzepatide not listed on the homepage (semaglutide only confirmed)
T2D.com

Graded #475 · C

Strengths

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Where it loses points

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard